Volume 2 Issue 1

Review and Recommendations for Drug Testing in Substance Use Treatment Contexts

Adi Jaffe, Sean Molnar, Nicole Williams, Emily Wong, Therese Todd, et al.
Drug and alcohol use have been associated with substantial impairments in functioning in a number of settings including driving [1], the work place [2], family functioning [3] and military service [4, 5].

Internet Addiction by Using the Smartphone-Relationships between Internet Addiction, Frequency of Smartphone Use and the State of Mind of Male and Female Students

Liron Ben-Yehuda, Liel Greenberg and Aviv Weinstein
In recent years, the use of Smartphones got a lot of attention due to their possible physiological, psychological and behavioral effects.

Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term

Kenneth Blum, Rajendra D. Badgaiyan, Eric R. Braverman, Kristina Dushaj, Mona Li, et al
Unlike other drugs of abuse such as alcohol, nicotine, opiates/opioids, the FDA has not approved any agent to treat psychostimulant dependence. Certainly, it is widely acceptable that dopaminergic signaling is a key factor in both the initiation and continued motivation to abuse this class of stimulant substances.

KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit?

Thomas McLaughlin, Marcelo Febo, Thomas Simpatico, Rajendra D. Badgaiyan, Debmalya Barh, et al.
Major Depressive Disorder (MDD) is a condition that affects approximately 12% of the population [1] and recurs at a rate between 50-85% regardless of treatment [2]. Treatment resistant depression (TRD) is considered if patients
do not show alleviation of depressive symptoms after at least two trials of antidepressants from different pharmacologic classes [3].

Off Label Use of Suboxone for Treatment Resistant Depression

George Kamajian, Robert Cable, Jonathan Greco, Brady Laughlin and Tanya deGroot
Major Depressive Disorder (MDD) is a condition that affects approximately 12% of the population [1] and recurs at a rate between 50-85% regardless of treatment [2].